Correlation Between Legend Biotech and Agios Pharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Legend Biotech and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Legend Biotech and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Legend Biotech Corp and Agios Pharm, you can compare the effects of market volatilities on Legend Biotech and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Legend Biotech with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Legend Biotech and Agios Pharm.

Diversification Opportunities for Legend Biotech and Agios Pharm

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Legend and Agios is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Legend Biotech Corp and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Legend Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Legend Biotech Corp are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Legend Biotech i.e., Legend Biotech and Agios Pharm go up and down completely randomly.

Pair Corralation between Legend Biotech and Agios Pharm

Given the investment horizon of 90 days Legend Biotech Corp is expected to under-perform the Agios Pharm. But the stock apears to be less risky and, when comparing its historical volatility, Legend Biotech Corp is 1.05 times less risky than Agios Pharm. The stock trades about 0.0 of its potential returns per unit of risk. The Agios Pharm is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  3,032  in Agios Pharm on August 27, 2024 and sell it today you would earn a total of  2,536  from holding Agios Pharm or generate 83.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Legend Biotech Corp  vs.  Agios Pharm

 Performance 
       Timeline  
Legend Biotech Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Legend Biotech Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Agios Pharm 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Agios Pharm are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Agios Pharm displayed solid returns over the last few months and may actually be approaching a breakup point.

Legend Biotech and Agios Pharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Legend Biotech and Agios Pharm

The main advantage of trading using opposite Legend Biotech and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Legend Biotech position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.
The idea behind Legend Biotech Corp and Agios Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like